Published in Prostate on September 11, 2014
Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol (2005) 11.63
Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer (2009) 9.33
Gonadal steroids and body composition, strength, and sexual function in men. N Engl J Med (2013) 8.47
Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol (1979) 6.96
The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene (2007) 5.14
Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev (2011) 5.02
JNK signaling in apoptosis. Oncogene (2008) 4.72
ERK and cell death: mechanisms of ERK-induced cell death--apoptosis, autophagy and senescence. FEBS J (2009) 4.05
ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation. EMBO J (1995) 3.86
ERK1/2 MAP kinases: structure, function, and regulation. Pharmacol Res (2012) 3.48
Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice. Nat Med (1997) 3.46
The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation. J Biol Chem (1996) 3.38
The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention. Mol Cancer (2007) 3.28
Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Immunity (2013) 3.22
Testosterone and estradiol among older men. J Clin Endocrinol Metab (2005) 2.63
Estrogens as endogenous genotoxic agents--DNA adducts and mutations. J Natl Cancer Inst Monogr (2000) 2.55
JNK signaling pathway is a key modulator in cell death mediated by reactive oxygen and nitrogen species. Free Radic Biol Med (2005) 2.54
Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol Metab (2001) 2.42
Non-classical p38 map kinase functions: cell cycle checkpoints and survival. Int J Biol Sci (2008) 2.18
Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway (Review). Int J Oncol (2003) 1.91
The evolving role of oestrogens and their receptors in the development and progression of prostate cancer. Eur Urol (2008) 1.90
Bisphenol S disrupts estradiol-induced nongenomic signaling in a rat pituitary cell line: effects on cell functions. Environ Health Perspect (2013) 1.89
Plasma membrane estrogen receptors. Trends Endocrinol Metab (2009) 1.85
TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation. Cell Death Differ (2012) 1.72
The biological role of estrogen receptors alpha and beta in cancer. Crit Rev Oncol Hematol (2004) 1.55
Quantitative measurement of estrogen-induced ERK 1 and 2 activation via multiple membrane-initiated signaling pathways. Steroids (2004) 1.31
Membrane estrogen receptor-alpha levels predict estrogen-induced ERK1/2 activation in MCF-7 cells. Breast Cancer Res (2004) 1.26
The role of diethylstilbestrol in the treatment of prostate cancer. Urology (2001) 1.25
Membrane-associated estrogen receptor signaling pathways in human cancers. Clin Cancer Res (2007) 1.24
Membrane estrogen receptor-alpha levels in MCF-7 breast cancer cells predict cAMP and proliferation responses. Breast Cancer Res (2004) 1.20
Caspase activation pathways: some recent progress. Cell Death Differ (2009) 1.18
The roles of membrane estrogen receptor subtypes in modulating dopamine transporters in PC-12 cells. J Neurochem (2008) 1.13
Induction of apoptosis by diethylstilbestrol in hormone-insensitive prostate cancer cells. J Natl Cancer Inst (1996) 1.11
p16(INK4a) and the control of cellular proliferative life span. Carcinogenesis (1999) 1.08
Mitochondrial mechanisms of estrogen neuroprotection. Brain Res Rev (2007) 1.07
Nongenomic actions of estradiol compared with estrone and estriol in pituitary tumor cell signaling and proliferation. FASEB J (2008) 1.04
Steroid hormone-induced effects on membrane fluidity and their potential roles in non-genomic mechanisms. Life Sci (2000) 1.03
Membrane estrogen receptor-alpha-mediated nongenomic actions of phytoestrogens in GH3/B6/F10 pituitary tumor cells. J Mol Signal (2009) 0.98
The involvement of reactive oxygen species (ROS) and p38 mitogen-activated protein (MAP) kinase in TRAIL/Apo2L-induced apoptosis. FEBS Lett (2002) 0.96
Androgen deprivation therapy as primary treatment for prostate cancer. J Clin Endocrinol Metab (2011) 0.94
Proliferative and anti-proliferative effects of dietary levels of phytoestrogens in rat pituitary GH3/B6/F10 cells - the involvement of rapidly activated kinases and caspases. BMC Cancer (2009) 0.94
Necroptosis: biochemical, physiological and pathological aspects. Pathol Oncol Res (2011) 0.94
The mechanism of necroptosis in normal and cancer cells. Cancer Biol Ther (2013) 0.93
Inhibition of the MEK/ERK signaling pathway by the novel antimetastatic agent NAMI-A down regulates c-myc gene expression and endothelial cell proliferation. Eur J Biochem (2002) 0.87
Regulation of cyclin D1 expression and cell cycle progression by mitogen-activated protein kinase cascade. Kidney Int (1999) 0.86
Low-dose diethylstilbestrol for the treatment of advanced prostate cancer. Urol Oncol (2011) 0.86
Endocrine disruption via estrogen receptors that participate in nongenomic signaling pathways. J Steroid Biochem Mol Biol (2011) 0.86
17beta-Estradiol metabolites affect some regulators of the MCF-7 cell cycle. Cancer Lett (1996) 0.79
p38 MAPK regulates G1-S transition in hypoxic cardiac fibroblasts. Int J Biochem Cell Biol (2011) 0.79
Measurement of diethylstilbestrol in plasma from patients with cancer of the prostate. Cancer Res (1981) 0.78
Rapid and opposite effects of cortisol and estradiol on human erythrocyte Na+,K+-ATPase activity: relationship to steroid intercalation into the cell membrane. Life Sci (1999) 0.76
Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Reprod Toxicol (2007) 4.04
In vitro molecular mechanisms of bisphenol A action. Reprod Toxicol (2007) 3.69
Why public health agencies cannot depend on good laboratory practices as a criterion for selecting data: the case of bisphenol A. Environ Health Perspect (2008) 3.27
Xenoestrogens at picomolar to nanomolar concentrations trigger membrane estrogen receptor-alpha-mediated Ca2+ fluxes and prolactin release in GH3/B6 pituitary tumor cells. Environ Health Perspect (2005) 2.53
Bisphenol S disrupts estradiol-induced nongenomic signaling in a rat pituitary cell line: effects on cell functions. Environ Health Perspect (2013) 1.89
Combinations of physiologic estrogens with xenoestrogens alter ERK phosphorylation profiles in rat pituitary cells. Environ Health Perspect (2010) 1.52
Estradiol activates mast cells via a non-genomic estrogen receptor-alpha and calcium influx. Mol Immunol (2006) 1.51
Xenoestrogen-induced ERK-1 and ERK-2 activation via multiple membrane-initiated signaling pathways. Environ Health Perspect (2004) 1.35
Maternal bisphenol a exposure promotes the development of experimental asthma in mouse pups. Environ Health Perspect (2010) 1.35
Quantitative measurement of estrogen-induced ERK 1 and 2 activation via multiple membrane-initiated signaling pathways. Steroids (2004) 1.31
Mechanisms of membrane estrogen receptor-alpha-mediated rapid stimulation of Ca2+ levels and prolactin release in a pituitary cell line. Am J Physiol Endocrinol Metab (2004) 1.30
Membrane estrogen receptor-alpha levels predict estrogen-induced ERK1/2 activation in MCF-7 cells. Breast Cancer Res (2004) 1.26
Environmental estrogens induce mast cell degranulation and enhance IgE-mediated release of allergic mediators. Environ Health Perspect (2007) 1.20
Membrane estrogen receptor-alpha levels in MCF-7 breast cancer cells predict cAMP and proliferation responses. Breast Cancer Res (2004) 1.20
The roles of membrane estrogen receptor subtypes in modulating dopamine transporters in PC-12 cells. J Neurochem (2008) 1.13
Synergism between a serotonin 5-HT2A receptor (5-HT2AR) antagonist and 5-HT2CR agonist suggests new pharmacotherapeutics for cocaine addiction. ACS Chem Neurosci (2012) 1.06
Alkylphenol xenoestrogens with varying carbon chain lengths differentially and potently activate signaling and functional responses in GH3/B6/F10 somatomammotropes. Environ Health Perspect (2008) 1.04
Flawed experimental design reveals the need for guidelines requiring appropriate positive controls in endocrine disruption research. Toxicol Sci (2010) 0.99
Membrane estrogen receptor-alpha-mediated nongenomic actions of phytoestrogens in GH3/B6/F10 pituitary tumor cells. J Mol Signal (2009) 0.98
Serotonin 5-HT2C receptor protein expression is enriched in synaptosomal and post-synaptic compartments of rat cortex. J Neurochem (2010) 0.98
Regulation of the membrane estrogen receptor-alpha: role of cell density, serum, cell passage number, and estradiol. FASEB J (2002) 0.94
Proliferative and anti-proliferative effects of dietary levels of phytoestrogens in rat pituitary GH3/B6/F10 cells - the involvement of rapidly activated kinases and caspases. BMC Cancer (2009) 0.94
Synthesis and evaluation of dimeric derivatives of 5-HT(2A) receptor (5-HT(2A)R) antagonist M-100907. ACS Chem Neurosci (2011) 0.92
Differential regulation of dopamine transporter function and location by low concentrations of environmental estrogens and 17beta-estradiol. Environ Health Perspect (2009) 0.92
Mixtures of xenoestrogens disrupt estradiol-induced non-genomic signaling and downstream functions in pituitary cells. Environ Health (2013) 0.92
Intracellular signaling involved in estrogen regulation of serotonin reuptake. Mol Cell Endocrinol (2004) 0.90
Combinations of physiologic estrogens with xenoestrogens alter calcium and kinase responses, prolactin release, and membrane estrogen receptor trafficking in rat pituitary cells. Environ Health (2010) 0.88
Nongenomic mechanisms of physiological estrogen-mediated dopamine efflux. BMC Neurosci (2009) 0.88
Correlation of membrane glucocorticoid receptor levels with glucocorticoid-induced apoptotic competence using mutant leukemic and lymphoma cells lines. J Cell Biochem (2002) 0.86
Quantitative changes in intracellular calcium and extracellular-regulated kinase activation measured in parallel in CHO cells stably expressing serotonin (5-HT) 5-HT2A or 5-HT2C receptors. BMC Neurosci (2012) 0.83
Subchronic exposure to phytoestrogens alone and in combination with diethylstilbestrol - pituitary tumor induction in Fischer 344 rats. Nutr Metab (Lond) (2010) 0.81
Non-genomic effects of xenoestrogen mixtures. Int J Environ Res Public Health (2012) 0.81
Peptide inhibitors disrupt the serotonin 5-HT2C receptor interaction with phosphatase and tensin homolog to allosterically modulate cellular signaling and behavior. J Neurosci (2013) 0.81
Cell cycle regulation, neurogenesis, and depression. Proc Natl Acad Sci U S A (2008) 0.77